Skip to main content
BMEA logo

BMEA · Biomea Fusion, Inc.

Track BMEA — free
$2.03 +0.12 (+6.28%) At close · Sep 4
Market Cap
$147.14M
Shares
72.48M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.03 Open$1.90 Day$1.89–2.05 52W close$0.96–2.67 Avg vol 30d1.4M Short int9.8M · 13.5% float · 20.9d Short vol34% Last earningsMay 5, 2026 DataApr 2021–Sep 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Sep 29, 2026 Est · unconfirmed · in 3 wks
filed Aug 5, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
Trailing 12 months
Net income (TTM)
−$32.54M
Trailing 12 months
Revenue growth YoY
+0.0%
Year over year
Operating margin
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+78.1%
Year over year · more shares
Price change (1Y)
+10.9%
Trailing year
Short interest
13.5%
Latest settlement · 20.9 days to cover
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 14.5 · calm Equity put/call 0.58
Technical
price trend
Buy
50 / 200-day cross Golden cross
Price vs 200-day avg +48%
above
Price vs 50-day avg +45%
above
RSI (14) 81
overbought
MACD trend Positive
52-week position 63%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +61%
trailing
6-month return +62%
trailing
YTD return +64%
this year
Relative strength +47%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Golden cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Distributing
-5% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
13.55% of float · ▼ -2.0% MoM · 20.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
62 holders — near 3-yr low, contrarian setup
Squeeze score 89
high risk · 0–100
Fundamentals
Fair
EPS growth +69%
Y/Y
Free cash flow $-70.7M
Quant / Vol
risk profile
Very High
Volatility 90%
annualized · 1-yr
Max drawdown −64%
past year
ATR 6.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 4
50 / 200-day cross
Golden cross Bullish
Price vs 200-day avg
+48% Bullish
Price vs 50-day avg
+45% Bullish
RSI (14)
81 Bearish
MACD trend
Positive Bullish
52-week position
63% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) Golden cross
50d $1 › 200d $1 — 50d above 200d
Institutional flow Distributing
-5% holders QoQ · +10 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
13.55% of float · ▼ -2.0% MoM · 20.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
62 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $2 · 63% Range high $3
vs 200-day avg +48% vs 50-day avg +45% 50-day above 200-day golden cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BMEA
Biomea Fusion, Inc.
this stock
$147.14M +63.7% 13.5%
VRTX
Vertex Pharmaceuticals Inc / Ma
$138.42B +20.5% +46.2% 31.8 1.6%
REGN
Regeneron Pharmaceuticals, Inc.
$85.22B +7.2% +20.8% 20.5 2.3%
ARGX
Argenx SE
$64.25B +22.9% 1.9%
CSLLY
Csl Ltd
$60.55B 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
62
% held
36.1%
Net QoQ
+1.3M sh
Top holder
FMR LLC
Held Float
View
Held by Funds
Fund positions
26
View
Short & Settlement
Short Interest Falling
Shares short
9.8M
Days to cover
20.9d
Change
-196.0K sh
View
Short Volume
Short vol %
34%
As of
Sep 4, 2026
Short Total
View
Fails to Deliver
FTD shares
7.4K
Value
$9.3K
As of
Aug 6, 2026
View
Off-Exchange
Off-exchange %
52.9%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Net income (FY)
$-61.8M
EPS diluted
$-1.18
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 5, 2026
This year
13
View
Proposed Sales
Value
$48.2M
Shares
1.5M
Filed
May 19, 2023
View
Exempt Offerings
Offering
$56.0M
Filed
Jan 15, 2021
View
Earnings & Events
Earnings Calls
Last call
Jun 4, 2026
View

Performance

5D 20D 120D MTD YTD
BMEA +17.3% +61.1% +62.4% +20.8% +63.7%
SPY +0.1% -0.4% +15.1% +0.4% +12.9%
vs SPY +17.2% +61.5% +47.3% +20.4% +50.8%
Key facts CIK 1840439 CUSIP 09077A106 13F (30d) 44 filings 44 filers Visit website Investor relations